Detalhe da pesquisa
1.
A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials.
Diabetes Obes Metab
; 21(1): 120-128, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30091218
2.
Glucagon-like peptide-1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial.
Obesity (Silver Spring)
; 31(2): 350-362, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695055
3.
Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes.
J Nucl Med
; 63(5): 794-800, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503957
4.
Imaging of the Glucagon Receptor in Subjects with Type 2 Diabetes.
J Nucl Med
; 62(6): 833-838, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097629
5.
A Metabolomic Signature of Glucagon Action in Healthy Individuals With Overweight/Obesity.
J Endocr Soc
; 5(9): bvab118, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34337278
6.
Prolonged Glucagon Infusion Does Not Affect Energy Expenditure in Individuals with Overweight/Obesity: A Randomized Trial.
Obesity (Silver Spring)
; 29(6): 1003-1013, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34029448
7.
Automated GMP-Compliant Production of [68Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans.
Pharmaceuticals (Basel)
; 13(8)2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32752075
8.
Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes.
Sci Rep
; 10(1): 16758, 2020 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028880
9.
Tolerability, safety, and pharmacokinetics of the novel cathepsin A inhibitor SAR164653 in healthy subjects.
Clin Pharmacol Drug Dev
; 5(1): 57-68, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27119579
10.
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.
J Clin Oncol
; 22(1): 175-84, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14701780
11.
EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study.
Psychopharmacology (Berl)
; 175(3): 382-8, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15007535